Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus (Luc Reporter)

Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-78172-1 100 µl - -

3 - 15 business days*

1,223.00€
BPS-78172-2 1 ml (500 µl x 2) - -

3 - 15 business days*

5,762.00€
 
The Spike (Epsilon B.1.429 Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with... more
Product information "Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus (Luc Reporter)"
The Spike (Epsilon B.1.429 Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 B.1.429 Variant Spike (Genbank Accession #QHD43416.1 with B.1.429 variant mutations, see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter (Figure 1), therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (B.1.429 Variant) (SARS-CoV-2) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 B.1.429 variant in a Biosafety Level 2 facility. Spike Mutations in B.1.429 Variant: S13I W152C L452R D614G
Keywords: 2,
Supplier: BPS Bioscience
Supplier-Nr: 78172

Properties

Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2

Handling & Safety

Storage: -80°C
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus (Luc Reporter)"
Write a review
or to review a product.
Viewed